January 04, 2026 ChainGPT

JV: XRP Under $2 Is 'One of the Greatest Blessings' — He's Buying, Urges 4-Year Hold

JV: XRP Under $2 Is 'One of the Greatest Blessings' — He's Buying, Urges 4-Year Hold
Crypto commentator JV is calling XRP trading below $2 “one of the greatest blessings of this lifetime” — and he’s putting his money where his mouth is. In a recent X post the analyst said he’s actively accumulating XRP, naming it his top crypto holding as he positions for a potential altcoin bull run. What JV holds and why - Primary crypto holding: XRP (actively accumulating). - Other crypto positions: Bitcoin, WLFI, Solana, XLM, HBAR and VET. - Top stock/crypto equities: ABTC and XXI. - Rationale: JV says he’s using crypto exposure to hedge the dollar’s devaluation. He noted his XRP position is up over 600% since 2020, while the dollar has allegedly lost nearly 20% of purchasing power — reinforcing his long-term, buy-and-hold strategy. A repeated call to long-term holders JV reminded followers that five years ago he told people they would be “legends” if they bought XRP at $0.17 and held for four years. He’s now issuing a similar call: buy XRP under $2 and hold for the next four years. He emphasized that investing success comes from “time in the market,” not timing it, warning that many traders get “wrecked” chasing quick gains and perfect entries. Analyst price cues to watch - Short term: Crypto analyst TARA projects a push to $2.30, saying XRP could reach that resistance if it can hold the $1.88 support level. - Long term: Egrag Crypto reiterated a bullish macro view, suggesting XRP could reach double digits (targets of $10–$11) as it holds above the 21 EMA and builds a base for the next move. Market context XRP has bounced in the last 24 hours alongside Bitcoin’s rally to $90,000, trading around $2 at the time of writing — up more than 9% over the past day, per CoinMarketCap. Bottom line: JV sees the current sub-$2 price as a rare buying window for long-term investors, while analysts point to $1.88 as a critical short-term support and $2.30 (near-term) and $10+ (macro) as upside targets. Read more AI-generated news on: undefined/news